Tramadol Treatment for Chemotherapy-induced Mucositis Pain in Children

Michal Yaffe Ornstein, Daniel Stocki, Dror Levin, Rina Dvir, Michal Manisterski, Sivan Berger-Achituv, Hila Rosenfeld Keidar, Yair Peled, Shoshana Hazan, Tom Rosenberg, Noga Oppenheimer, Ronit Elhasid*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Mucositis, a painful and debilitating condition, is a common side effect of chemotherapy. The role of tramadol in the treatment of mucositis in pediatric patients has not yet been determined. In this retrospective study, we evaluate whether tramadol as single agent achieved a reduction of pain intensity among oncologic children admitted for mucositis. In total, 34 of 54 (63%) episodes were treated with tramadol alone and achieved adequate pain relief. Tramadol's side effects were mild and manageable.

Original languageEnglish
Pages (from-to)E487-E492
JournalJournal of Pediatric Hematology/Oncology
Volume44
Issue number2
DOIs
StatePublished - 1 Mar 2022

Keywords

  • chemotherapy
  • children
  • mucositis
  • pain
  • tramadol

Fingerprint

Dive into the research topics of 'Tramadol Treatment for Chemotherapy-induced Mucositis Pain in Children'. Together they form a unique fingerprint.

Cite this